WHO WE
ARE

 

EndyMed Medical Ltd., (ENDY:TASE), established in 2007, offers energy based medical aesthetic treatment systems for professional and consumer markets. EndyMed's innovative, FDA cleared 3DEEP® radiofrequency technology is a highly effective solution for nonablative and fractional tightening and contouring treatments for the face, neck and body, acne scar and stretchmark treatment, cellulite reduction and RF Microneedling treatments.
EndyMed’s unique, patented 3DEEP technology delivers RF energy 3 layers deep into the skin, without any pain or risk, stimulating the skin's  natural collagen production to remove wrinkles and noticeably lift and tighten skin. With 6 RF generators, 3DEEP is the newest, most innovative RF skin technology available today. 3DEEP delivers focused RF energy to the depth of the dermis with minimal epidermal heat or pain, and is perfectly safe and suitable for all skin types and colors.

OUR VISION: TO BE AN INDUSTRY LEADER
IN THE PROFESSIONAL AND HOME USE MEDICAL AESTHETIC MARKETS BY

Developing innovative and effective technologies
based on excellent clinical results.
Creating a new market segment, Beauty Tech, which
merges the medical and cosmetics worlds.

 

 

THE TEAM

A professional multi-disciplinary team with extensive experience in the medical aesthetic industry.

Yossi Bar On

CEO

Yossi joins EndyMed as CEO after participating as an active member of the EndyMed Board of Directors. Prior to his new position at EndyMed, Yossi served as the Chief Financial and Operating Officer at Sanara Ventures, an innovative investment launchpad for the field of healthcare-technology. Yossi has also served as the Chief Financial Officer at Dynamix Pharmaceuticals, a small-molecule drug Discovery and Development Company, and also held a similar position at Mirage Innovations, a developer and Manufacturer Company of cutting-edge Personal Video Displays. Yossi also served as the CFO of Tegrity (acquired by McGraw-Hill Education), an award-winning lecture capture solutions company. Yossi holds a B.A. in Accounting & Economics, from the Hebrew University in Jerusalem and is a current member of the Israeli Institute of Certified Public Accountants.

Zvika Lifschitz

CFO

Zvika Lifschitz joined EndyMed in September 2016 as CFO. Mr. Lifschitz brings with him 20 years’ experience in multi-national high-tech industries, as well as the real-estate and services industries (Valens, Tessera, Resolute, Shiron and Manofim). Mr. Lifschitz has a varied, broad experience set in strategic planning, growth execution, investor relations, fund raising from international investors, leading teams, operations, taxation, incentive plan, M&As, taxation, GAAP, IFRS, ESOP and incentive plans.

Eran Ishay

VP R&D

Eran Ishay joined EndyMed in 2018 after holding senior management positions in the medical device and semiconductor capital equipment industry for over 20 years. Eran held R&D and product line management positions within the FPD Division at Orbotech. Most recently, he held the position of COO and VP R&D in Expanding Orthopedics Inc. He holds a BSc in Mechanical Engineering and an MBA from Tel Aviv University.

Lior Cohen

VP Sales

Lior Cohen joined Endymed as director of sales for APAC region in April 2013. Lior brings to EndyMed 17 years of experience in the area of International sales management. Prior to joining EndyMed, Lior served as a Regional Sales Manager in Asia at Alma Lasers Ltd. Prior to Alma Lasers, he served as Europe and Latin America sales manager for Mckesson (NYSE: MCK) a Fortune 15 company, focused on Healthcare IT solutions in Radiology and Cardiology.  Lior holds a Bachelor’s Degree in Business Administration and LL.B, Bachelor of Law as well as member of the Israeli bar association.

Atzmon Ben Shlush

VP Operations

Atzmon joined ENDYMED in July, 2017, bringing with him over 30 years of experience in operational and production management. Prior to joining ENDYMED, Atzmon served as VP Operations at Aspect Imaging and Mango DSP, working with large operational systems and sub-contractor management. Atzmon holds a Bachelor's Degree in Industrial Engineering and Management from the University of Tel Aviv.

Paul Iannelli

VP Sales, ENDYMED Inc.

Paul Iannelli joined ENDYMED Medical Inc., the US office, in 2013 in the position of National Sales Director, and was promoted to Vice President of Sales US in 2015.  In 2018 Paul has taken on the role of General Manager of ENDYMED Inc.  Paul brings many years experience in the field of medical aesthetics, having held positions at Eclipse Aesthetics and Alma Lasers prior to joining ENDYMED.

Dr. Lehavit Akerman

Medical Advisor

Dr. Lehavit Akerman, a dermatological specialist, brings more than 18 years of medical experience in the field of dermatology and aesthetic dermatology to ENDYMED. In addition to her role as Medical Advisor to ENDYMED Medical, Dr. Akerman works at her three private aesthetic and laser clinics, offering a wide variety of innovative anti-aging dermatological and aesthetic treatments.  Dr. Akerman also serves as the head of the dermatology department at the Rothschild Clinic for Clalit Health Services.

Dr. Itzchak Angel

Pharmaceutical and Regulatory Advisor

Dr. Itzchak Angel joins  ENDYMED as Pharmaceutical and Regulatory Advisor. Dr. Angel is an accomplished executive in the Pharmaceutical Industry, with over 35 years’ experience in guiding strategic drug and business development in both large and emerging companies, as well as interfacing with high profile regulatory, government and industry leaders.  Dr. Angel’s areas of expertise include ethical drug development; discovery, research and development; international regulatory affairs; and biologics, small molecules, stem cells, drug delivery and medical devices.  Dr. Angel’s many professional accomplishments include 80 scientific publications and 9 patents.

Yoram Harth‚ MD

Founder

A respected dermatologist and experienced serial entrepreneur, Dr. Harth was a founder, president and medical director of CureLight Medical Ltd, which marketed photo-dermatology treatment systems globally. Dr. Harth is an expert in product innovation and has an in-depth understanding of the market needs in aesthetic medicine. Previously, he was a research fellow at Columbia Presbyterian Hospital in New York City and a faculty member of the American Academy of Dermatology.

THE ENDYMED
PARTNERSHIP

The EndyMed Partnership Advantage - solid partnerships with exceptional support. Join the EndyMed family and enjoy a unique and low risk business model that supports every aspect of your business. With effective marketing, premium clinical services and top-notch customer service programs, EndyMed ensures a high return on investment from the very beginning.

 

THE ENDYMED PARTNERSHIP
PROGRAM OFFERS

Flexible Business plan with high ROI - one treatment platform with a full complement of handpieces that offer superior aesthetic treatments for the face, neck and body. 

Superior clinical support - EndyMed is the most clinically validated Rf technology available, with over 40+ peer-reviewed clinical studies published. We supply our partners with enhanced clinical support, along with comprehensive and consistent clinical training sessions worldwide and yearly clinical workshops.

Customer support - we commit to providing our partners with the highest standard of customer service possible. From our dedicated customer service platform, EndyCare, Free software upgrades available through the EndyCare customer service portal Flexible upgrade programs available on new technologies

Marketing support - EndyMed offers a wide range of marketing collateral and assets to help bring traffic to your practice.

 

 

Advanced Physician/Clinic finder

International media exposure

Patient marketing assets

Full marketing support

  

 

 
(c) Copyright 2016-2017 ENDYMED MEDICAL. All rights reserved